Suppr超能文献

影响原发性中等大小血管闭塞性卒中取栓决策的因素。

Factors influencing thrombectomy decision making for primary medium vessel occlusion stroke.

机构信息

Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.

Medical Imaging, Fakultní nemocnice u sv Anny v Brně, Brno, Czech Republic.

出版信息

J Neurointerv Surg. 2022 Apr;14(4):350-355. doi: 10.1136/neurintsurg-2021-017472. Epub 2021 May 4.

Abstract

BACKGROUND

We aimed to explore the preference of stroke physicians to treat patients with primary medium vessel occlusion (MeVO) stroke with immediate endovascular treatment (EVT) in an international cross-sectional survey, as there is no clear guideline recommendation for EVT in these patients.

METHODS

In the survey MeVO-Finding Rationales and Objectifying New Targets for IntervEntional Revascularization in Stroke (MeVO-FRONTIERS), participants were shown four cases of primary MeVOs (six scenarios per case) and asked whether they would treat those patients with EVT. Multivariable logistic regression with clustering by respondent was performed to assess factors influencing the decision to treat. Dominance analysis was performed to assess the influence of factors within the scenarios on decision making.

RESULTS

Overall, 366 participants (56 women; 15%) from 44 countries provided 8784 answers to 24 scenarios. Most physicians (59.2%) would treat patients immediately with EVT. Younger patient age (incidence rate ratio (IRR) 1.24, 99% CI 1.19 to 1.30), higher National Institutes of Health Stroke Scale (NIHSS) score (IRR 1.69, 99% CI 1.57 to 1.82), and small core volume (IRR 1.35, 99% CI 1.24 to 1.46) were positively associated with the decision to treat with EVT. Interventionalists (IRR 1.26, 99% CI 1.01 to 1.56) were more likely to treat patients with MeVO immediately with EVT. In the dominance analysis, factors influencing the decision in favor of EVT were (in order of importance): baseline NIHSS, core volume, alteplase use, patients' age, and occlusion site.

CONCLUSIONS

Most physicians in this survey were interventionalists and would treat patients with MeVO stroke immediately with EVT. This finding supports the need for robust clinical evidence.

摘要

背景

我们旨在通过一项国际横断面调查,探索卒中医生对治疗原发性中等血管闭塞(MeVO)卒中患者行即刻血管内治疗(EVT)的偏好,因为目前针对这些患者的 EVT 并无明确的指南推荐。

方法

在调查 MeVO-FRONTIERS(评估血管内再通治疗的合理性和新目标以治疗卒中的原发性中等血管闭塞)中,参与者观看了 4 例原发性 MeVO(每个病例 6 个场景),并被问及他们是否会对这些患者行 EVT 治疗。采用按应答者聚类的多变量逻辑回归评估影响治疗决策的因素。进行优势分析以评估各场景内因素对决策的影响。

结果

共有来自 44 个国家的 366 名参与者(56 名女性,占 15%)对 24 个场景中的 8784 个答案进行了回答。大多数医生(59.2%)会立即对患者行 EVT 治疗。较年轻的患者年龄(发生率比 1.24,99%置信区间 1.19 至 1.30)、更高的国立卫生研究院卒中量表(NIHSS)评分(发生率比 1.69,99%置信区间 1.57 至 1.82)和较小的核心体积(发生率比 1.35,99%置信区间 1.24 至 1.46)与 EVT 治疗决策呈正相关。介入医师(发生率比 1.26,99%置信区间 1.01 至 1.56)更倾向于对 MeVO 患者立即行 EVT 治疗。在优势分析中,有利于 EVT 决策的因素(按重要性顺序)依次为:基线 NIHSS、核心体积、阿替普酶的使用、患者年龄和闭塞部位。

结论

该调查中的大多数医生为介入医师,他们会对 MeVO 卒中患者立即行 EVT 治疗。这一发现支持需要开展强有力的临床研究证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验